Clinical Trials
85 trialsDNET
Asian Institute of Gastroenterology, India
Beta plus
University Hospital, Basel, Switzerland
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
European Institute of Oncology
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Molecular Targeting Technologies, Inc.
FiReNEN
IRCCS San Raffaele
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
IRCCS San Raffaele
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
AHS Cancer Control Alberta
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
RGS-GEP-NET
European Institute of Oncology
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Surufatinib in G3 Neuroendocrine Tumors
Qilu Hospital of Shandong University
Registry on NEN Patients and COVID-19
European Institute of Oncology
Radio-Marker
Erasmus Medical Center
REGOMUNE
Institut Bergonié
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Provectus Pharmaceuticals
GICCA
Leiden University Medical Center
A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
Taizhou Hanzhong biomedical co. LTD
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Fundación de investigación HM
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)
University Hospital, Antwerp
Camune
University Hospital, Strasbourg, France
Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm
Peking Union Medical College Hospital
Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma
Peking Union Medical College Hospital
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm
Fudan University
LOLA
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis
Fudan University
MetNET-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment
University of Warmia and Mazury
FENET-2016
University Hospital of Ferrara
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
British Columbia Cancer Agency
MONET
European Institute of Oncology
Image-Enhanced Endoscopy in the Gastrointestinal Tract
King's College Hospital NHS Trust
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
Sheba Medical Center
Impact of Peptides and Chelators on Somatostatin Receptor Antagonists
Peking Union Medical College Hospital
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
University of Warmia and Mazury
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
University of Aarhus
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
PVNET
Royal Free Hospital NHS Foundation Trust
POLNETS_PRRT
University of Warmia and Mazury
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Molecular Insight Pharmaceuticals, Inc.
Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
Peking University
MicroTEND
Assistance Publique - Hôpitaux de Paris
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
Tel-Aviv Sourasky Medical Center
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
Tel-Aviv Sourasky Medical Center
RMPanNET
Fudan University
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
Peking Union Medical College Hospital